3.4. SETDB1 Silencing Inhibits PD-L1 Expression and Promotes the T Cell-Mediated Cytotoxicity to Tumor Cells via the FOSB/miR-22/BATF3 Axis. This evidence concerns the gene CD274 and neoplasm.